Last reviewed · How we verify
Flavonoids
At a glance
| Generic name | Flavonoids |
|---|---|
| Also known as | Daflon |
| Sponsor | Services Hospital, Lahore |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency (PHASE1)
- Improving Physical Ability and Cellular Senescence Elimination in HIV (PHASE2)
- Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes (PHASE2)
- Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). (NA)
- Tart Cherry Juice for Sleep in Older Adults With Insomnia: A Pilot Study of Feasibility and Comprehensive Mechanisms (NA)
- Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects (PHASE2, PHASE3)
- The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules (PHASE4)
- Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flavonoids CI brief — competitive landscape report
- Flavonoids updates RSS · CI watch RSS
- Services Hospital, Lahore portfolio CI